NVIDIA
NVDA
Adobe
ADBE
Tesla
TSLA
4
Netflix
NFLX
5
Qualcomm
QCOM
US Stock MarketDetailed Quotes
INMB INmune Bio
- 7.950
- -0.090-1.12%
Close Mar 14 16:00 ET
- 7.950
- 0.0000.00%
Post 20:01 ET
180.40MMarket Cap-3.65P/E (TTM)
8.415High7.770Low224.71KVolume8.150Open8.040Pre Close1.79MTurnover1.53%Turnover RatioLossP/E (Static)22.69MShares12.72052wk High4.67P/B116.82MFloat Cap4.32052wk Low--Dividend TTM14.69MShs Float30.370Historical High--Div YieldTTM8.02%Amplitude2.200Historical Low7.960Avg Price1Lot Size
INmune Bio Key Stats
EPS
According to the latest financial report of INmune Bio, the latest earnings per share (TTM) for the company is -0.60. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about INmune Bio's free cash flow? The latest report shows it as -6.99M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of INmune Bio shows that the company's current ratio is 2.59, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of INmune Bio, the quick ratio is 2.53, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of INmune Bio? The latest ROE figure is -31.93%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of INmune Bio, the total asset return on investment (ROA) is -22.98%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check INmune Bio's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of INmune Bio, the net profit margin is -78.75K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025